Ignite Creation Date:
2024-05-05 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00723060
Status:
COMPLETED
Last Update Posted:
2011-08-08
First Post:
2008-07-24
Brief Title:
Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Study Overview
Official Title:
Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder Randomized Double-blind Multi-center Study
Status:
COMPLETED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVE The objective of this study is to compare the effect and safety of conventional dose 20mg and high dose 40mg of escitalopram in patients with obsessive-compulsive disorder OCD
OVERVIEW OF STUDY DESIGN Prospective Randomized Active-controlled Double-blind Multi-center Clinical Trials STUDY POPULATION Patients with OCD EFFICACY EVALUATIONS Y-BOCS D-YBOCS HAM-D HAM-A CGI-S -I GAF OCI-R SAFETY EVALUATION Adverse Events Serious Adverse Events UKU
OVERVIEW OF STUDY DESIGN Prospective Randomized Active-controlled Double-blind Multi-center Clinical Trials STUDY POPULATION Patients with OCD EFFICACY EVALUATIONS Y-BOCS D-YBOCS HAM-D HAM-A CGI-S -I GAF OCI-R SAFETY EVALUATION Adverse Events Serious Adverse Events UKU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None